University of Edinburgh
Western General Hospital, Edinburgh, United Kingdom
Stuart Ralston holds the Versus Arthritis Chair of Rheumatology at the University of Edinburgh and is a Consultant rheumatologist in NHS Lothian where he is clinical lead for the osteoporosis service and clinical director of the rheumatology service. He has researched widely on the molecular and genetic basis of bone and joint diseases. and has a special interest in the pathogenesis and management of Paget’s disease of bone. He is joint editor-in-chief of Calcified Tissue International and editor of Davidson's Principles and Practice of Medicine. He was chair of the Commission for Human Medicines (CHM) for the UK Medicines and Healthcare Regulatory Authority (MHRA) between 2013 and 2021 and continues to act as an advisor to CHM on matters relating to Medicines for Women’s Health and Rheumatology.
Paget's Disease of Bone: An Ancient Disease with Modern Genetic Findings
Sunday, November 12, 2023
4:00 PM – 4:15 PM PT
Disclosure(s): AstraZeneca: Grant/Research Support (Terminated, April 30, 2023); Eli Lilly: Donation of IMP for clinical trial (Ongoing); Kyowa Kirin: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Donation of IMP for clinical trial (Terminated, May 31, 2022); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 14, 2022), Support to attend scientific meeting (Terminated, September 14, 2022)
